These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
599 related items for PubMed ID: 20373454
1. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL. Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454 [Abstract] [Full Text] [Related]
2. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, Fisher RA, Ham J, Sanyal AJ. Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298 [Abstract] [Full Text] [Related]
3. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A. Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128 [Abstract] [Full Text] [Related]
4. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Malik SM, Devera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J. Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117 [Abstract] [Full Text] [Related]
5. Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy. Sutedja DS, Gow PJ, Hubscher SG, Elias E. Transplant Proc; 2004 Oct; 36(8):2334-7. PubMed ID: 15561241 [Abstract] [Full Text] [Related]
6. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC. Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [Abstract] [Full Text] [Related]
7. Non-alcoholic steatohepatitis in children. Nanda K. Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336 [Abstract] [Full Text] [Related]
9. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM. Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462 [Abstract] [Full Text] [Related]
10. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Angulo P, Keach JC, Batts KP, Lindor KD. Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511 [Abstract] [Full Text] [Related]
11. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Nayak NC, Vasdev N, Saigal S, Soin AS. Hum Pathol; 2010 Mar; 41(3):425-30. PubMed ID: 19954815 [Abstract] [Full Text] [Related]
12. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U. Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814 [Abstract] [Full Text] [Related]
13. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Harrison SA, Torgerson S, Hayashi PH. Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785 [Abstract] [Full Text] [Related]
14. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated? Helling TS, Helzberg JH, Nachnani JS, Gurram K. Surg Obes Relat Dis; 2008 Sep; 4(5):612-7. PubMed ID: 18226970 [Abstract] [Full Text] [Related]
15. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. Malik SM, Gupte PA, de Vera ME, Ahmad J. Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869 [Abstract] [Full Text] [Related]
16. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. Palekar NA, Naus R, Larson SP, Ward J, Harrison SA. Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452 [Abstract] [Full Text] [Related]
17. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Abrams GA, Kunde SS, Lazenby AJ, Clements RH. Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453 [Abstract] [Full Text] [Related]
18. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP. Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228 [Abstract] [Full Text] [Related]
19. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ, Chan HL. Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244 [Abstract] [Full Text] [Related]
20. Prevalence and clinical associations of posttransplant fatty liver disease. Lim LG, Cheng CL, Wee A, Lim SG, Lee YM, Sutedja DS, Da Costa M, Prabhakaran K, Wai CT. Liver Int; 2007 Feb; 27(1):76-80. PubMed ID: 17241384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]